Device Industry Hopes Trump’s FDA Nominee Will Support Medtech Innovation

 
• By Sarah Karlin-Smith
  
FDA building.
Approval marks Hyloris' second in the US this year after Maxigesic IV • Source: Shutterstock

More from Medtech Insight

More from Regulation